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Abstract
The mitochondrion within human cells in tissue culture is pleomorphic and highly dynamic. The organelle mass can exist as thousands of
small ovoids or as one continuous reticulum. In either state, the mitochondrial mass is in constant thermal motion, as well as moving in
c 0.8-Am jumps that are determined by, and related to, attachments with cytoskeletal elements. Many protein complexes, such as the
pyruvate dehydrogenase (PDH) complex and DNA containing nucleoids, are dispersed through the mass and as though fixed by attachments
to membranes, such that they can become distributed to all of the individual small ovoid mitochondria when the reticulum becomes
fragmented. This leads us to propose that a replicating module is the repeating unit of mitochondrial structure. Studies to examine
heterogeneity of functioning within the organelle mass are briefly reviewed.
D 2002 Elsevier Science B.V. All rights reserved.
Keywords: Replicating module; Mitochondrion; Structure– function relationship
Mitochondria are involved in and, in several cases, direct
a range of cellular processes including energy production,
intracellular Ca + regulation, fatty acid oxidation, sterol
biogenesis and programmed cell death or apoptosis. We
are studying the structure–function relationships that under-
lie the organelle’s ability to perform this variety of func-
tions, often at the same time. Here, we review our initial
experiments and summarize findings that lead us to suggest
that the mitochondrial mass is composed of repeating units
built around the multiple mitochondrial nucleoids, which we
call ‘repli-units’.
Mitochondrial form and distribution are variable [1]. In
human cell lines, such as 143B (osteosarcoma), HeLa and
fibroblast cells, the organelle is pleomorphic and exists in an
equilibrium between reticular and fragmented forms [2,3].
This equilibrium is influenced by the cell cycle. The
mitochondrion is predominantly fragmented and appears
as small ovoid organelles in the S and M phases, and
predominantly as a reticulum in other phases, such as in
Gj [4,5]. In both states, the organelle is tightly associated
with, and the distribution determined by, interactions with
cytoskeletal elements [1,6]. We have recently examined the
movements of the mitochondrion in 143B cells by a novel
technique, Fourier Imaging Correlation Spectroscopy
(FICS), as well as by digital video microscopy [7]. These
studies show that the organelle is highly dynamic, under-
going constant short-distance thermal motions, superim-
posed on which are jumps where the mitochondria move
in large (0.8 Am) steps. Individual jumps require energy and
are lost when oxidative phosphorylation is inhibited by
antimycin or by uncouplers. They also depend on interac-
tions with both microtubules and microfilaments, and are
lost when these cytoskeletal elements are disrupted.
To fully describe mitochondrial structure–function rela-
tionships, it will be necessary to know how many different
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proteins are present, their stoichiometries, their organization
and dynamics in situ. Present estimates are that there are
upwards of 1000 different proteins in the organelle to carry
out all the necessary functions, only a fraction of which
have been identified so far. These various proteins are
distributed between three compartments, an outer mem-
brane, inner boundary membrane and cristal membrane,
along with three spaces, the intermembrane space between
outer and inner membranes, the intracristal space, and the
matrix space [8,9]. Most proteins are localized to one
compartment only, but there are exceptions including the
respiratory chain enzymes and the ATP synthase, which are
mostly in the cristal membranes, but also present in the inner
boundary membrane, albeit in significantly lower amounts
[10].
To analyze the arrangement of proteins in situ, we are
tagging components of interest (proteins and mitochon-
drial DNA replication factors) by making chimeras with
green fluorescent protein (GFP). This allows us to exam-
ine distribution and movements in live cells using high-
resolution fluorescence imaging. As a second approach,
we use our growing collection of monoclonal antibodies,
each highly specific to key proteins, to detect their
distribution in fixed cells, again using fluorescence micro-
scopy. To date, two large components, the pyruvate
dehydrogenase (PDH) complex [11], and the mitochon-
drial nucleoid [4] (a complex of mtDNA and associated
proteins [12]), have been examined by one or more of
these methods. Both are distributed at discrete positions in
the mitochondrial reticulum (Fig. 1) and behave as if
attached in a way that prevents their movement along the
reticular tubes. As a result, they are seen as punctate
spots along the reticulum. This contrasts with unconju-
gated GFP and red fluorescent protein (RFP), which,
when targeted in cells to occupy the matrix space, are
able to freely diffuse along the reticulum. Such findings
suggest a model in which major components are concen-
trated at membrane surfaces (attached to cristae, as well
as the inner boundary membrane), leaving channels for
rapid diffusion of small molecules such as substrates and
ions, as well as small proteins, along the reticulum.
When the reticulum undergoes fragmentation, each
ovoid mitochondrion could get copies of PDH and the
nucleoid if the fission and fusion events that switch the
different morphologies occur at discrete sites between
nucleoids [13–15]. We suggest that these ‘‘cleavage’’
sites separate well-organized domains of metabolic
enzymes, as well as several copies of the mitochondrial
ribosomes and protein entry sites (the TIM/TOM com-
plexes). In this respect, the mitochondrial mass can be
considered as a set of repeating units around core
mtDNA-containing nucleoids. Each is maintained in jux-
taposition by tracks of cytoskeletal elements, so that they
can be alternately linked together or disassembled by
fission or fusion at their ends. Each repeating unit could
contain all of the enzymes of the organelle, or some may
be only in subsets of the repli-unit, which would lead to
heterogeneity of some functions in the mitochondrial
mass. Even if structurally homogenous, there can be
Fig. 1. (A) Distribution of PDH complex within the mitochondrion in
osteosarcoma cells 143B. Subunit E1a of the PDH complex was labeled by
fusion to GFP and the mitochondrial network was stained with mitotracker
red. The co-localization of GFP-E1a and the mitochondrial network
appears yellow and reveals regions of bright fluorescence, interconnected
by filaments with a lower signal. (B) Detail of the organization of the
mitochondrial reticulum stained with GFPpH targeted to the matrix space in
143B osteosarcoma cells. Cells were grown in medium containing galactose
for more than 30 doublings and visualized without fixative agent. Each
tubule contains several donut-shaped structures. (C) Labelling of
mitochondrial DNA (mtDNA) in Hela cells by fluorescence in situ
hybridization (FISH green). The mitochondrial network was stained with
mitotracker red. The co-localization of mtDNA and the mitochondrial
network appears yellow and reveals a heterogeneous punctate distribution
of the mitochondrial genome.
R.A. Capaldi et al. / Biochimica et Biophysica Acta 1555 (2002) 192–195 193
functional heterogeneity as a result of variation in local-
ized influx and efflux of metabolites.
To investigate the functional heterogeneity of the
mitochondrial mass, we are employing GFP biosensors
[16,17]. To date, we have directed both a pH sensor GFP
and a redox sensor GFP to the matrix space and meas-
ured the properties of this space in bulk within single
cells. Both probes are ratiometric and so the values of pH
or redox state obtained, and the changes in these param-
eters in response to metabolic changes, are independent of
the concentration of the probes. Fig. 2 shows data for the
redox probe. The mitochondrial matrix is significantly
reduced in HeLa cells grown on glucose with EoV at
around  0.300 V at pH 7 and 30j C. This translates into
a redox potential of close to  368 mV at the observed
pH of the matrix space under such conditions. The
implication is that the redox state of the matrix space is
not determined predominantly by glutathione, as others
have suggested [18], but by NADH. NADH is a two-
electron donor, while the redox GFP can only accept
electrons at the Cys–Cys bond one at a time. Therefore,
there must be enzymes, such as pyridine nucleotide–
disulfide oxidoreductases, which can accept electron pairs
from NADH and provide these to the GFP in the matrix
space. One example is the dihydrolipoyl dehydrogenase
of the PDH complex, which we have shown can reduce
the GFP in vitro in the presence of oxidized lipoamide
and NADH. Cells grown in galactose and glutamine have
a steady-state redox poise in the matrix space, consider-
ably more oxidized than those grown in glucose. This is
not surprising if the cells are producing ATP by oxidative
phosphorylation when grown in galactose and, therefore,
utilizing NADH, while in glucose human cell lines derive
energy predominantly by glycolysis.
The redox state of any solution containing oxidants
and reductants can be determined as the ensemble aver-
age, but this property is really a ‘‘point function’’ and
highly heterogeneous depending on near-neighbor inter-
actions of reactants [19]. Our efforts are now to examine
the heterogeneity of both pH and redox state. One way
this can be accomplished is to localize the biosensor
GFPs by fixing them as chimeras with enzymes of
interest. Thus, we have recently localized the redox
GFP to the close vicinity of nucleoids by making a
chimera with the protein Twinkle, a helicase that binds
tightly to mtDNA (described in Ref. [20]).
In summary, our studies focus on the detailed struc-
tural and functional topology of mitochondria in cells. It
is first necessary to describe these features in normal cells
but, ultimately, we plan to examine altered cells derived
from patients with mitochondrial dysfunction, due to
mutation of OXPHOS components, as in Leighs disease,
MELAS and many other metabolic defects (reviewed in
Refs. [21,22]). It will also be possible to examine
mitochondrial changes that occur during apoptosis much
more definitively than now possible.
Fig. 2. (A) Fluorescence excitation spectra of ros1GFP (redox probe)
targeted to the mitochondrial matrix space in Hela cells suspension.
Emission was recorded at 511 nm and GFP was fully oxidized by adding 1
mM H2O2 or fully reduced with 10 mM DTT. (B) Single cell image of Hela
cells expressing rosGFP1 targeted to the matrix space of the mitochondrion.
Cells were cultured on glass coverslips (22 22 mm) in glucose medium
and directly visualized at 511 nm (excitation 480 nm) using an upright Zeiss
Axioskop2 microscope equipped with a 100 Neofluar objective (1.3
N.A.). (C) RosGFP1 redox state in Hela cells grown in glucose or galactose
medium. Cells were grown to 60–70% confluence on a 15-cm tissue
culture plate, harvested and suspended in PBS buffer (10 mM Na/K
phosphate, pH 7.4, 137 mM NaCl, 2.7 mM KCl, 0.5 mM CaCl2, 0.5 mM
MgCl2) supplemented with glucose (25 mM) or galactose (10 mM)/
glutamine (8 mM). The maxima of reduction and oxidation of rosGFP1
were determined in situ by adding, respectively, H2O2 (1 mM) or DTT (to
10 mM) in the cuvette.
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